For the Inventor, By the Inventor

Enter assignee name

Dabur Research Foundation

USPTO Granted Patents = 29

Forward Citations = 212

Loading Chart...

Loading Chart...

49 inventors (with patents filed for the assignee):

Rama Mukherjee (17 out of 25 patents)

Manu Jaggi (17 out of 22 patents)

Anand C Burman (16 out of 24 patents)

4. Sudhanand Prasad (11 out of 15 patents)

5. Anu T Singh (10 out of 13 patents)

6. Sunder Ramadoss (9 out of 9 patents)

7. Archna Mathur (6 out of 6 patents)

8. Dhiraj Khattar (3 out of 13 patents)

9. Anand Vardhan (3 out of 4 patents)

10. Rajan Sharma (3 out of 3 patents)

11. Mohammad Jamshed Ahmad Siddiqui (3 out of 3 patents)

12. Kamal K Kapoor (3 out of 3 patents)

13. Chandra Kant Katiyar (3 out of 3 patents)

14. Gautam R Desiraju (2 out of 8 patents)

15. Mukesh Kumar (2 out of 6 patents)

29 patents: Sort by Forward Citations

1. 7179937 - Cyclopentenone derivatives for cancer therapy (2007-02-20),

2. 7173006 - Drug comprising synthetic peptide analogs for the treatment of cancer (2007-02-06),

3. 7094755 - Vasoactive intestinal peptide analogs (2006-08-22),

4. 7060678 - Peptides comprising furanoid sugar amino acids for the treatment of cancer (2006-06-13),

5. 6989371 - Bombesin analogs for treatment of cancer (2006-01-24),

6. 6949557 - Hydroanthracene based compounds as anticancer agents (2005-09-27),

7. 6949513 - Polypeptides of covalently linked synthetic bioactive peptide analog(s) for treatment of cancer (2005-09-27),

8. 6828304 - Peptides for treatment of cancer (2004-12-07),

9. 6670345 - Betulinic acid derivatives for inhabiting cancer growth and process for the manufacture of betulinic acid (2003-12-30),

10. 6656970 - Method and compositions for solubilization of pentacyclic triterpenes (2003-12-02),

11. 6632832 - Anti-cancer activity of carvedilol and its isomers (2003-10-14),

12. 6613793 - Anticancer activity of imino acid conjugates or methylglyoxal (2003-09-02),

13. 6608174 - Radiolabeled vasoactive intestinal peptide analogs for diagnosis and radiotherapy (2003-08-19),

14. 6599541 - Composition for treatment of drug resistant bacterial infections and a method of treating drug resistant bacterial infections (2003-07-29),

15. 6596755 - Oral formulation of methylglyoxal and its imino acid conjugates for human use (2003-07-22),

Dabur Research Foundation (DRF) is a leading Indian research organization focused on scientific research and innovative product development in the field of healthcare and lifestyle. With a commitment to improving human well-being, DRF conducts extensive research in Ayurveda, traditional medicine, and modern approaches to develop safe and effective healthcare solutions. DRF collaborates with top-tier national and international universities, research institutions, and industry partners to drive advancements in the pharmaceutical, nutraceutical, and cosmeceutical sectors. Through its cutting-edge facilities and multidisciplinary team, Dabur Research Foundation strives to positively impact global health and contribute to sustainable development.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

29 Patents

#2 in

#68 in India

#21,868 in the World

Dabur Research Foundation

Forward Citations = 212

49 inventors:

Rama Mukherjee (17 out of 25 patents)

Manu Jaggi (17 out of 22 patents)

Anand C Burman (16 out of 24 patents)

4. Sudhanand Prasad (11 out of 15 patents)

5. Anu T Singh (10 out of 13 patents)

Please report any incorrect information to support@idiyas.com

Loading…